Monday, December 13, 2010

QuantaLife Gets $17.2M

Pleasanton-based QuantaLife, a developer of PCR equipment for the genetic sequencing market, said Friday that it has raised $17.2M in a Series B financing round. The round came from Paladin Capital Group, Merieux Developpement, and Vital Financial LLC. The firm said the new funding will go towards establishing commercial operations for its first product, and for accelerated development of targeted diagnostic tests. More information »